| Stage | TT | % of rev | ETN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.8B | 100.00% | $8.9B | 100.00% | ETN ×1.32 |
| Gross profit | $2.4B | 35.28% | $3.1B | 34.70% | TT +0.6pp |
| Operating income | $1.3B | 19.87% | $1.6B | 17.76% | TT +2.1pp |
| Pre-tax income | $1.3B | 19.01% | $1.4B | 15.31% | TT +3.7pp |
| Net income | $1.1B | 15.59% | $1.1B | 12.06% | TT +3.5pp |
| Stage | TT | ETN | Gap · A − B |
|---|---|---|---|
| Revenue | $6.8B100.00% | $8.9B100.00% | ETN ×1.32 |
| Gross profit | 35.28%$2.4B | 34.70%$3.1B | TT +0.6pp |
| Operating income | 19.87%$1.3B | 17.76%$1.6B | TT +2.1pp |
| Pre-tax income | 19.01%$1.3B | 15.31%$1.4B | TT +3.7pp |
| Net income |
| 15.59%$1.1B |
| 12.06%$1.1B |
| TT +3.5pp |
None
No disclosed counterparties: TT.